Topics

MolMed Pulls Zalmoxis Cell Therapy In EU

06:57 EDT 11 Oct 2019 | SCRIP

The Italian biotech will redirect investment, initially reserved for Zalmoxis, to other activities that would better meet its business objectives.

      

Related Stories

 

Original Article: MolMed Pulls Zalmoxis Cell Therapy In EU

NEXT ARTICLE

More From BioPortfolio on "MolMed Pulls Zalmoxis Cell Therapy In EU"

Quick Search

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...